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Objective: To compare the findings from a qualitative and a natural language processing
(NLP) based analysis of online patient experience posts on patient experience of the
effectiveness and impact of the drug Modafinil.
Methods: Posts (n = 260) from 5 online social media platforms where posts were
publicly available formed the dataset/corpus. Three platforms asked posters to give a
numerical rating of Modafinil. Thematic analysis: data was coded and themes generated.
Data were categorized into PreModafinil, Acquisition, Dosage, and PostModafinil and
compared to identify each poster’s own view of whether taking Modafinil was linked
to an identifiable outcome. We classified this as positive, mixed, negative, or neutral
and compared this with numerical ratings. NLP: Corpus text was speech tagged
and keywords and key terms extracted. We identified the following entities: drug
names, condition names, symptoms, actions, and side-effects. We searched for simple
relationships, collocations, and co-occurrences of entities. To identify causal text, we split
the corpus into PreModafinil and PostModafinil and used n-gram analysis. To evaluate
sentiment, we calculated the polarity of each post between −1 (negative) and +1
(positive). NLP results were mapped to qualitative results.
Results: Posters had used Modafinil for 33 different primary conditions. Eight themes
were identified: the reason for taking (condition or symptom), impact of symptoms,
acquisition, dosage, side effects, other interventions tried or compared to, effectiveness
of Modafinil, and quality of life outcomes. Posters reported perceived effectiveness as
follows: 68% positive, 12% mixed, 18% negative. Our classification was consistent with
poster ratings. Of the most frequent 100 keywords/keyterms identified by term extraction
88/100 keywords and 84/100 keyterms mapped directly to the eight themes. Seven
keyterms indicated negation and temporal states. Sentiment was as follows 72% positive
sentiment 4% neutral 24% negative. Matching of sentiment between the qualitative and
NLP methods was accurate in 64.2% of posts. If we allow for one category difference
matching was accurate in 85% of posts.
Conclusions: User generated patient experience is a rich resource for evaluating real
world effectiveness, understanding patient perspectives, and identifying research gaps.
Walsh et al. Evaluating Effectiveness With NLP
Both methods successfully identified the entities and topics contained in the posts.
In contrast to current evidence, posters with a wide range of other conditions found
Modafinil effective. Perceived causality and effectiveness were identified by bothmethods
demonstrating the potential to augment existing knowledge.
Keywords: social media, natural language processing, effectiveness, causality, patient experience, evidence-
based medicine, sentiment analysis, qualitative/NLP comparison
INTRODUCTION
Increasing numbers of people use social media and other online
spaces as either a first or second line health information (1) and
exchange resource (2, 3) with estimates suggesting the volume of
online health related data will have grown by 300% between 2017
and 2020 (4). This unstructured freeform textual data contains a
mass of contextually grounded detail about the perceptions and
health concerns of those who post online. It has potential to add
to clinical understanding, either by adding to knowledge where
existing evidence is inconclusive (5), or in aiding understanding
of real-world usage (6), although the methods for analyzing it are
still at an early stage of development (7–13).
Although evidence based medicine (EBM) has been
instrumental in raising healthcare standards and developing
clinical knowledge, it has acknowledged weaknesses (14–16),
including a divide between patient priorities and the research
agenda (15–20) and a structural reliance on evidence from RCTs
and systematic reviews (17, 18, 20, 21). Spontaneously generated
online patient experience (SGOPE) is a data resource which could
help address these weaknesses. However, the lack of established
methodologies to analyze it inhibits its use (22–25). Natural
language processing (NLP) refers to the use of computational
techniques and algorithms that aim to interpret the semantic
meaning from large volumes of unstructured text (26). A rapidly
developing area (27), it is being used to explore health related
social media usage (28–32), detecting drug or device related
adverse events from user generated content (33, 34), generating
new understanding about treatment switching and adherence
behavior (35, 36) and as a surveillance tool for infectious disease
outbreaks (37, 38) and suicide risk (12) although little work has
been carried out into its use for assessing effectiveness (35).
This study was undertaken in preparation for a larger study of
SGOPE data onModafinil using NLP. Our aimwas to understand
the data in depth in order to develop relevant NPL analysis for the
subsequent study.
Study objectives were to
• Qualitatively explore context, health conditions, and
symptoms where Modafinil is used, its perceived effectiveness
and impact, and identify indications of causation of effect
and outcomes.
Abbreviations: EBM, Evidence based medicine; EHR, Electronic health records;
NLP, Natural language processing; QOL, Quality of life; RCT, Randomized
controlled trial; SGOPE, Spontaneously generated online patient experience; UGC,
User generated content.
• Use NLP and corpus linguistics to identify topics, create an
ontology of entities, relationships, and causal text, and evaluate
overall sentiment toward perceived effectiveness of Modafinil.
• Evaluate the ability of NLP methods to identify the
qualitative findings.
Why Modafinil?
Sudden onset cognitive dysfunction and fatigue are debilitating,
and distressing symptoms seen in a variety of conditions
and clinical presentations. Modafinil is an out of patent oral
wakefulness-promoting drug, first developed in the late 1990s,
shown to be relatively safe, and with low abuse potential (39).
Currently indicated only for narcolepsy in the UK (40, 41), its US
FDA status enables clinicians to prescribe it “off label” to improve
cognition or fatigue symptoms inmany other conditions. Around
90% of its prescribed US usage is “off label” (42). Modafinil has
been considered a potential therapy for a range of conditions
(43), including ADHD (44), multiple sclerosis (45, 46), premature
ejaculation (47), depression (48), Parkinson’s disease (49),
chemotherapy related fatigue (50, 51), traumatic brain injury
(52), and cocaine dependence (53). Findings have been mixed,
with systematic reviews generally inconclusive, showing either
insufficient (52, 54–56) or low quality evidence (56–58). Previous
studies have commented on the lack of research into either long
term (39) or “as required” use (59). However, despite the lack of
conclusive trial based evidence there appears to be a substantial
amount of online discussion suggesting that there are people for
whom it has made a significant difference to their symptoms and
quality of life (60).
METHODS
Study Design
Qualitative inductive thematic analysis (61), and basic NLP
analysis, of spontaneously generated online patient experience
data (SGOPE) (see Figure 1). We compared the results of the
NLP analysis with those from the qualitative analysis.
Data Selection and Preparation
In January 2017, using google searches, we identified websites
containing publicly available text about the experience of
Modafinil use. We defined publicly available as where the data
identified was available to view by anyone without any form
of login, password or registration. We selected sites containing
single comment “User review” posts so the type of text was
similar from the different sites enabling comparison across
the data sources. The final selection included: AskAPatient
(62), Drugs.com (63), and WebMD (64) which provided short
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FIGURE 1 | Overview of study design.
accounts of condition-based experiences, and Erowid (65) and
ModUp where the posts were longer with greater detail of
symptoms, side-effects, and self-experimentation. Online spaces
can be transient and unfortunately the ModUp site no longer
exists online, but all the others are still visible. From the sites
we identified posts made between 1st Jan 2002 and 17th Jan
2017, and searched for individual posts about Modafinil (or
variant names Provigil, Armodafinil, Nuvigil) using the site
search engine.We then used random number generation to select
260 posts from across the five sites for further analysis. This
volume of data was likely to be sufficient to reach data saturation
for the qualitative analysis and be sufficient for linguistic analysis.
Each site had its own data structure with a variety of fields.
Age and gender self-definition were optional on each of the sites.
We standardized the data using the following steps:
• Standardizing field names across sources.
• Translating/encoding coded values: e.g., M/F or
male/female.
• Standardizing numerical ratings scores for experience
of Modafinil. Erowid and ModUp had no numerical rating;
AskAPatient had a rating from 1 to 5 and drugs.com from 1
to 10 for effectiveness of Modafinil, and WebMD had ratings
for effectiveness, ease of use, and satisfaction, each from 1 to 5.
For the latter, the average of the three scores was calculated. We
standardized all ratings to a value of between 1 and 10.
• Ages and duration of taking Modafinil, where given as an
identifiable field, were grouped into ranges, and standardized
across the sources.
• Posting date simplified to PostYear.
All poster identification was removed, and a unique code
allocated to each post. To generate initial descriptive statistics
we calculated post lengths, before coding and quantifying any
included gender, age groups, duration of taking Modafinil, and
numeric ratings.
Ethical Considerations
The ethical issues surrounding the use of SGOPE data for
research purposes are complex and continue to evolve (66, 67).
Making a clear distinction between public and private spaces
online can be difficult (68, 69). SGOPE can be classified as
publicly available data (70) but as it was originally collated by the
online sites and contains detail of individuals it does not fit the
narrower definition of open data which can be freely used, re-
used, and distributed by anyone (71). At the time of the design of
this study there was a lack of clear guidance from UK Research
Councils or other organizations (68, 72). In our methods we tried
to minimize the potential for any form of harm.
There has been significant recent debate around expectations
of privacy (73, 74). It is impossible to know the motivation,
or expectation of privacy of each poster in publishing their
content, but posters writing on sites that are password protected
or restricted to members may have greater expectations that
their privacy will be protected. Concerns exist that individuals
could be identified from the posts they make, and that they may
consequently suffer harm from some unforeseen use of the data.
Potential harms range from unwanted commercial marketing
use to profiling that could negatively impact future insurance
or career choices (75). However, some studies looking at user
attitudes found that social media users were generally positive
toward their posts being used for research provided that they
were protected from harm and that the research had potential
benefit (73). There are examples of social media communities
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TABLE 1 | Using categories to identify causal text and perceived effectiveness.
Sequence Post categories Text describing
Base state PreModafinil Symptoms + context
Action: Acquisition/dosage Took/did/prescribed
Consequence PostModafinil Effect on symptoms/side
effects/context/QOL
deliberately formed in open online spaces to enable individuals
to come together to form a voice that is heard by health systems
(76, 77).
No IP address or other geographical data was collected, all
forms of usernames were removed, and the dates of the post
reduced to a year value to minimize any risk of reidentification
(69). Use of this type of data is covered under the doctrine of fair
use (78, 79). However, we successfully arranged a data sharing
agreement with AskApatient and unsuccessfully sought to put
one in place withModUp. Erowid position themselves as working
with academics and medical experts and state that they generally
agree to research use. However, we received no response from
our repeated requests. All of the sites included invited posters
to submit experience reports for publication on the respective
platform. Content from drugs.com (80) andWebMD (81) carried
clear messages to posters that posts were publicly viewable and
could be read, collected, and used by others.
Qualitative Analysis
Following familiarization with the posts, the data was coded and
the codes merged into themes. We used MaxQDA software (82),
using an iterative process of code identification and review as we
progressed through the data. The coding and theme generation
was done by JW, with discussion and input from FG & JC.
For each theme we counted the number of posts in which
they appeared.
Evaluating Effectiveness
We categorized text within each post into one of four
broad categories, PreModafinil, Acquisition, Dosage, and
PostModafinil. These categories align with the base state, action,
and consequence sequence required to indicate a possible
perceived causal effect (83, 84) (Table 1). We compared the
coded sections of each post across the sequence categories to
identify the poster’s own view of whether taking Modafinil was
linked to an causal belief and identifiable outcome.
We classified each post for perceived effectiveness (positive,
mixed, negative, neutral, unclear) (Table 2). We assessed each
post in isolation; balancing the positive and negative aspects of
language used, reported benefits and side effects, and reference
to the continued use or cessation. Fifty posts were initially
independently classified by two teammembers and discrepancies
discussed. JW then classified the remaining 210 posts.
For posts which had associated numerical ratings we
categorized ratings of 0–3 as negative, 4–7 as mixed, and 8–10
as positive. Using chi squared test we compared our manually
assessed classification with the poster’s rating.
NLP
The narrative fields were extracted to create a corpus. Due to the
small size of this exploratory dataset, we used a corpus linguistics
tool, SketchEngine (85) for the structural analysis of the text.
Typical NLP projects return best results from very large datasets,
while corpus linguistics can be used on smaller data sets of the
size also amenable to qualitative analysis. Corpus linguistics and
NLP share some similar analysis techniques (86). Pre-processing
for both NLP and corpus linguistics begins by dividing the text
into tokens representing the smallest possible linguistic unit.
Each token was assigned a part-of-speech (POS) tag from the
English TreeTagger POS tagset with Sketch Engine modifications
(87). We used stemming and lemmatization to assign inflected
words to the same term, reducing the number of inflectional
forms of a word and reducing variants to a common base (88, 89).
We used case independent word frequency and term
extraction. Similar to TF-IDF of NLP, term extraction identifies
the terms most specific to the text by calculating term frequency
in the text compared to frequency of the same term in the
reference corpus. For our reference corpus we used the English
Web corpus 2013 (enTenTen13) (90), a corpus of 19 billion
words collected from online sources. We extracted the top 500
specific keywords and terms. The top 100 of each indicated the
most prevalent topics. The least frequent were used to identify
instances of spelling variations or non-words; these were added to
the domain specific dictionary intended for use in the next stage
of the project.
Entity Identification
To identify relevant entities, we used the following POS tokens
tagged as nouns:
• Drug Names—both name variations of Modafinil and other
drugs; those taken previously, concurrently, or subsequently
in addition to some that may have no relevance to the post.
• Condition Names—identifiable condition names were
categorized from term extraction analysis. Sleep related
disorders were classified in line with the ICSD3 classification
systems (91).
• Symptoms—symptoms of interest in this study relating to
fatigue or cognitive issues. Initial dictionary entries were
created from common synonyms, with further additions
identified from the previous analysis.
• Action—the action of taking Modafinil has two main
components: amount and frequency. Terms and phrases to
identify both were found within the posts and included in
the dictionary.
• Side Effects—term extraction was particularly useful in
identifying side effects that the poster described, as patients
often use a wide range of terms to describe them that may not
map easily to recognizable medical terms.
Relationship Identification
We used three methods to identify the relationships between
entities in order to understand the semantic meaning of the text:
1. POS tagging of verbs occurring between entities to indicate
simple relationships;
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TABLE 2 | Examples of sentiment grading.
Grade Explanation Example
Positive Overall positive. Ranged from overwhelmingly positive to
indicating that benefits outweigh the disadvantages
“Significantly improved my quality-of-life with the only side effect being minor occasional
headache” (2400)
Mixed Both positive and negative effects were reported; unclear
as to which sentiment prevailed
“It is a lifeline to me, but the side effects are many and do suck. Though i can honestly say,
i don’t find it addictive.” (1117)
Negative Predominantly negative, usually regarding side effects. “… feel really strange shaking overall out of sorts I am not falling asleep at work but feel so
weird I’m wired that I need to find something else” (1123)
Neutral No response or side effects noticed. “...didn’t notice any effect whatsoever, not even a side effect. “(330)
2. Collocation analysis (92) to reveal patterns and meanings that
may not be apparent from frequency lists or manual reading
of the texts;
3. Co-occurrence analysis: this assumes that if two entities co-
exist within so many words that there is an underlying
relationship between them. Unlike collocations, the relevant
words need not be adjacent to each other, but occur
within the same unit of text. Co-occurrences can highlight
relationships indicating a causal link such as a side effect,
outcome event, or demonstrate a negated drug event—one
which denies a causal relationship between the drug and
the event.
To identify possible causal text, we split the corpus into
to sub corpora based on the text categories PreModafinil
and PostModafinil (see section Qualitative Analysis above)
and used n-gram analysis on each, looking for phrases
between 3 and 5 words long that occurred at least five
times in the corpora. Where an ngram was ambiguous
we examined the co-location and co-occurrence analysis to
assist categorization.
Sentiment Analysis Using NLP
To evaluate sentiment we used the Python “TextBlob” package
(93) to calculate the polarity of each post as a value between −1
(negative) and+1 (positive). Pre-processing included converting
text to lower case, removing punctuation, and removal of the
default stop words.
Comparing the Two Methods
We manually mapped each of the 100 most frequent key words
and terms from the computational corpus analysis to the themes
that emerged from the qualitative analysis. Where a word/term
was ambiguous or related to negation, time or scale we placed
them in a separate group.
To compare NLP sentiment analysis to the qualitative
categorization of positive, mixed, neutral, or negative we used
two comparison scales. The first classifying a “mixed” result as
being in the range ±0.01 (Table 6) and the second widening the
“mixed” range to ±0.05 (Table 7). In both cases a polarity value
of 0 was mapped to Neutral.
Wemapped each of the 3–5 word length ngrams to the themes
from the qualitative analysis. Where an ngram could apply to
more than a single theme, we used the collocation and co-
occurrence techniques in order to map it to the theme or group
for which it was most prevalent.
We compared the NLP sentiment analysis with the qualitative
analysis results for perceived effectiveness of Modafinil as
follows: comparison of totals for each type of perceived
effectiveness/sentiment; comparison of analysis of individual
posts. The accuracy of the post level comparison was assessed
using a confusion matrix.
RESULTS
The dataset included posts with a total length of 72,427
words (average 279; minimum 15; maximum 2,384). Posts from
AskAPatient (30–417 words), Drugs.com (15–204), WebMD
(29–358), Erowid (44–2,384), and ModUp (125–1,030).
Of the posters, 158/260 (61%) identified their gender and
156/260 (60%) included their age, either as an integer or as
being within a range. From the two sites with 100% gender
identification, there were 65% female posters on AskAPatient
and 22% on Erowid. The defined age-groups ranged from
under 18 to over 75, with the largest age-group being
45–54 years.
The quantifiable length of time that posters stated they had
been taking Modafinil was included in 184/260 (70%) of posts.
Of these 34 (18.5%) had taken it for 7 days or less, 31 (17%) 8–31
days, 61 (33.1%) for between 2 and 12 months and 58 (31.5%) for
longer than 1 year.
Qualitative Analysis
We identified eight themes which we describe below.
Reason for Taking Modafinil
All posts were concerned with finding a solution for symptoms of
fatigue, sleep and or cognitive dysfunction. Although Modafinil
is only indicated for a single condition within the UK, 33
different health conditions were mentioned within this small
sample of 260 posts. The most frequent were central disorders
of hypersomnolence (mentioned in 26% of posts), depression
(22%), sleep related breathing disorders (16%), general fatigue
(9%), CFS/ME (7.5%), ADHD/ADD (6%), and MS (6%).
Other conditions included cancer, traumatic brain injury,
diabetes, epilepsy, fibromyalgia, autoimmune conditions, pain,
IBS, hepatitis C, or post stroke fatigue. Multi-morbidity was a
regular feature. While many posts referred to a single diagnosed
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condition, 23% referred to two concurrent conditions, 3% to
three and 1.5% to four.
Impact of Symptoms
Almost all posts contained detail of how these fatigue or
cognitive symptoms affect their lives, emotionally, socially,
and practically. Responses to their conditions included fear,
desperation, hopelessness, resignation, embarrassment, and guilt:
Life was miserable. I was being treated for depression and had even
considered suicide. There was no way out of this rut. [422]
I had resigned myself to life handicapped with fatigue, and I felt
really hopeless about it [321]
Frustration was a common theme, often at their own inability to
engage with “normal” life.
I couldn’t stand being this form of myself any longer—it’s not
me [424]
Symptoms were described as having considerable impact on
family and social relationships, putting a strain on marriages,
partnerships and affecting parenting:
My husband gets sick and tired of me being tired all the time and
particularly hates it when I have to have a nap [503]
Before Nuvigal I couldn’t keep my eyes open and live my normal
life with 3 boys! Now, after Nuvigal I can actually play with my
kids and be a normal mother. [2348]
The loss, or anticipated loss of a job featured in 47 (18%) of the
posts and 18 (7%) posters detailed their fear of driving, either
because they had experienced falling asleep at the wheel or were
concerned that they would.
Effectiveness of Modafinil
Posts were classified as follows: 68% positive, 18% mixed, and
12% negative; four posts were neutral (see Table 2). A total
of 181 posts had the potential to include a numeric rating of
the effectiveness of Modafinil of which 178 posters completed
the rating. The average value (after standardization) was 7.5/10.
We found no significant difference between the posters numeric
rating and our assessment (χ 3.3419, p= 0.3).
There was considerable variation in the proportion of posters
reporting positive effect of Modafinil across the different sites:
positive values ranged from 46 to 100%, mixed from 0 to 27%,
and negative from 0 to 25% (see Table 3).
Impact of Effectiveness on QOL
A recurring topic among those finding Modafinil effective, was
how it allowed them to return to what they felt was their personal
“normal” state rather than enhancing their abilities in any way.
This stuff is pretty amazing, i can actually have a normal day
rather than fighting just to get through one. It’s not what i feel but














Positive 46% 72% 78% 100% 61% 67%
Mixed 27% 15% 12% 0% 27% 18%
Negative 25% 13% 7% 0% 10% 13%
No effect 1% 0% 2% 0% 0% 1%
what i don’t feel which is the constant fatigue, without that life has
returned to “normal.” [1388]
Dosage
Of the 141 (55%) posts included text relating to Modafinil dosage
the reported dosage taken ranged from 25 g to 1,200mg per day
in one extreme case. Although clinical guidelines usually suggest
200–400mg daily (94), there are indications that a lower dose
was found to more effective for some posters, with 17 reporting
taking 100 mg/day. Tolerance was described as an issue for some,
with 51 (20%) posters commenting on an apparent reduced
effectiveness after weeks or months of regular daily use. Some
posters reported that stopping taking Modafinil for a few days
before resuming a daily dose appeared to restore its effectiveness
After a week or so, effects not as strong and can make you feel
paradoxically very tired. Take 2–3 days off, and it will resume
working. [2344]
whereas others felt it was better to take it only when they felt that
they would most benefit from it:
I did notice however that I have to take breaks from it for it to
remain effective. I now only take it if I have a full day planned and
have to go out, otherwise I stay at home and take a nap. [502]
The posts also illustrated how users have experimented to find a
dosage pattern that they find effective (Table 4). Almost half the
posts contained text detailing the variations in frequency they
had tried and those they found most effective. Comments also
included the cause/effect results of experimentation of increasing
or lowering the dose, taking before or after meals, with or
without alcohol and how that impacted on the side effects
and effectiveness
I found if i took 50mg every couple of days, and then 100mg on
busy days, it kept the headaches/migraines at bay. [1117]
Side Effects
Of the 260 posts, 128 (49%) specifically mentioned one or more
side effects they considered related to the use of Modafinil.
Thirty-four posts (13%) stated that they did not suffer any side
effects at all, while the remaining 98 (38%) did not mention
any specific side effect. Across the sample the most commonly
reported side effects were headaches (57), mental health/mood
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TABLE 4 | Qualitative analysis: dosage frequency.
Documents Percentage Percentage (valid)
Daily 53 20.38 44.92
As required 30 11.54 25.42
Twice daily 21 8.08 17.8
M-F 13 5 11.02
Unclear (variable) 10 3.85 8.47
Every other day 2 0.77 1.69
Posts with code(s) 118 45.38 100
Unspecified 142 54.62 –
Total 260 100
related (43), appetite (30), gastric (18), urinary (16), oral (16),
skin (15), cardiovascular (11), jittery (10), and difficulty sleeping
(10). Other side effects including difficulty sleeping, muscular,
vision effects, motor function, weight gain, tinnitus, shortness
of breath, magnified pain, neuropathy, lupus flare up, swollen
tongue, weight loss, and increased libido were mentioned by<10
posters. The impact of side effects varied, 12 posts described
them as minimal, while 13 felt they were temporary, passing
within a few days. Nine posters stated that they had stopped
taking Modafinil; eight due to side effects and one because of an
interaction with an MAOI antidepressant.
Acquisition of Modafinil
Detail of how the poster found out about or acquired Modafinil
was present in 136/260 (52%) posts, with 82 (31%) stating
they were prescribed Modafinil by a clinician, while 54 (21%)
discovered it through either their own research or via word
of mouth. Difficulties in obtaining it, either within the NHS
where its use is restricted to narcolepsy, or in the US where
insurance companies often will not cover the cost despite
clinicians prescribing it, were mentioned by 37/177 (21%) of
those finding Modafinil beneficial. Self-purchasing from online
sources was reported by 35 (13%) of posters:
Now because they say Modafinil is not a bi-polar medicine they
refuse to pay for it. I will not be able to afford the $650 a month.
Without it I wake with nightmares. It’s very sad insurance says they
know better than a group of doctors and 10 years of success using a
prescription [2098]
Other Interventions
Almost all posts included details of previously prescribed or tried
interventions including self-help or lifestyle changes, and any
interventions taken in combination with Modafinil. Posts often
include comparative descriptors both of effect and/or side effects
of the alternative intervention or combination.
I find modafinil it more effective than caffeine although the initial
effects seemed to wear off after about 8 hours or so. There are
definitely less side effects than with other prescription stimulants
such as phentermine or ritalin. [2016]
Causality
Among the 260 posts, we manually identified text relating to
the perceptions of the poster’s experience both pre and post
Modafinil in 209 (80%). Of these, 258 (99%) contained text
relating to the effect of taking Modafinil. Identification of causal
text was helped by the reported rapid onset of any effect, with
many posters who believe it to have an effect, either positive or
negative, noticing changes within an hour of taking it.
Comparing Qualitative and Corpus Results
Of the 100 highest frequency keywords 88 mapped directly to
qualitative themes, seven related to negation or scale and 5
could not be classified. Of the 100 highest frequency key terms,
84 mapped directly to the qualitative themes, seven referred to
negation and temporal aspects, and nine could not be classified
(Table 5).
Sentiment Analysis
The NLP TextBlob package returns sentiment polarity as a value
between −1 (negative) and +1 (positive). Of the 260 posts 188
(72%) indicated positive sentiment, 10 (4%) neutral and 62 (24%)
negative. The range of polarity values of posts was from−0.26 to
0.4. Tables 6, 7 show the results of comparing the classification
of each method for each post. Matching was accurate in 64%
of posts. If we allow for one category difference matching was
accurate in 85% of posts.
The 3–5-word ngram analysis on both the pre-Modafanil (35)
and post-Modafanil (106) text generated ngrams classified into
the eight themes and 6 categories reported in Table 8.
As with the keywords and keyterms we found that many of
these ngrams correlated with and mapped onto the themes that
emerged from the qualitative analysis. Others related specifically
to temporal, sequential, negation, or confirmation text that could
be used to identify phrases inferring causality. The frequently
occurring ngram “I have found that” seen in nine posts was used
to describe ways of taking the drug to maximize the effectiveness.
Examples of generic ngrams and the context in which they were
used are given in Table 9.
We were able to match ngrams to the expression of causal
analysis identified by the qualitative analysis (Table 10).
DISCUSSION
Within this exploratory study of the unstructured narrative
post content, both methods successfully demonstrated how the
majority of posters with a wide range of conditions found
Modafinil effective in reducing fatigue or cognitive symptoms.
In performing the human based qualitative study first, those
findings acted as an informal benchmark for the automated NLP
study. The eight themes generated reflected the main aspects
of patient experiences of an intervention. It also explored the
detailed context that was often included within the poster’s
evaluation, including the reasons for starting or stopping using
it, comparisons with other medications that they may have tried
or moved onto, side effects and tangible or intangible effects on
their quality of life.
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TABLE 5 | 100 highest frequency keywords and keyterms by topic.
Theme/type of text Keyword Keyterm
Drug Modafinil; provigil; nuvigil; armodafinil; modalert; nootropic;
modafanil; modafinal; modvigil; nuvigal; modavigil; moda;
200mg provigil;
Condition Narcolepsy; hypersomnia; apnea; idiopathic; fatigue; fibromyalgia;
cfs; insomnia;
Sleep apnea; daytime sleepiness; sleep cycle; chronic fatigue;
excessive sleepiness; sleep disorder; excessive daytime sleepiness;
extreme fatigue; severe sleep apnea; obstructive sleep apnea; shift
work; nerve entrapment;
Symptom Sleepiness; sleepy; tiredness; drowsiness; asleep; fatigue; drowsy;
procrastination; sleep; lethargy; nap; spaciness; procrastinate;
doze; irritable; tired; exhaustion
Head fog; daytime sleepiness; sleep cycle; chronic fatigue; excessive
sleepiness; term memory; day time; short term memory; anxious state;
afternoon fatigue; constant fatigue; brain fog;
Acquisition Reddit; mymodafinil; Prescription drug; sleep study;
Dosage mg; dose; tolerance; pill; 200mg dose; 200mg pill; full dose; first dose; second dose; empty
stomach; 100mg dose; second pill; 200mg provigil; 1st week; drink
plenty; daily dose;
Side effect Jittery; jitter; headache; hallucination; irritability; impulsiveness;
irritable; itchiness; appetite; nausea; grouchy; clench; bpm;
Side effect; dry mouth; smelly urine; heart rate; mild anxiety; slight
headache; unpleasant side; bad side; heart beat; negative side;
anxious state; jittery feeling
Other drug/intervention Stimulant; piracetam; ritalin; cpap; caffeine; amphetamine;
ephedrine; adderall; adrafinil; phenylephrine; bupropion; ssri; med;
pseudoephedrine; caffiene; methylphenidate; fluoxetine; cocaine;
Taking bupropion
Effect Wakefulness; awake; alertness; euphoria; enhancer; psychoactive;
nighter; schoolwork; talkative; lifesaver; palpitation; impulsiveness;
amped; chatty;
Term memory; cognitive enhancer; normal sleep; productive day;
mental acuity; normal sleep schedule; mental clarity; positive impact;
short term memory;
Outcome New person; normal sleep schedule; miracle drug; wonder drug;
Negation Didn’t; wasn’t; hasn’t; couldn’t; wouldn’t; hadn’t I didn’t; i wasn’t;
Temporal 1st week; first dose; second dose; hour period; entire day;
Scale Hyper
Ungrouped Comedown; sleepless; midterm, cephalon; had Sleep deprivation; side note; trouble sleeping; placebo effect; college
student; enhancing drug; study aid; year old male; work day;
TABLE 6 | Sentiment analysis confusion matrix [±0.01].
NLP
Qual ≥0.01 + =-0.01 to <0.01 0 ≤-0.01 Total
Positive 145 2 4 23 174 Agreed evaluation
Mixed 28 3 3 13 47 1 category different
Neutral 0 0 1 3 4 2 categories different
Negative 11 4 2 18 35 Completely opposite evaluation
Total 184 9 10 57 260
Accuracy 0.642
green - Agreed evaluation, beige - 1 category different, plum - 2 categories different, and red - completely opposite evaluation.
The sample size was too small to realistically expect good
results from the NLP analysis, but by using the corpus linguistics
tool which used some methods found in a full NLP approach
we were able to demonstrate how an NLP methodology could
be used on a much larger scale to both extract topics/themes,
expressions of perceived causality and evaluate effectiveness from
unstructured text.
As with a recent paper comparing grounded theory with topic
modeling on survey data (95), our NLP based methods
successfully identified many of the qualitative findings,
demonstrating how this form of data has the potential to
identify effectiveness and the topics discussed within the posts.
In terms of sentiment analysis, the results highlight some of
the current issues with NLP methods. Although both methods
show a majority of posters finding it effective for them, the
confusion matrices (Tables 6, 7) highlighted some of the issues
with applying generic sentiment analysis tools to health-related
data. Rule based methods that determine sentiment are based
on a lexicon of prelabelled words and the accuracy of the results
is heavily dependent on the data that the model was trained
on and the words that are considered important to that model.
The majority of the existing generic NLP sentiment analysis
tools were trained on either film, restaurant, or Amazon product
reviews as these represent some of the largest shared annotated
sentiment resources (11). Looking at some of the posts with
opposing categorizations (Table 11), demonstrates how many of
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TABLE 7 | Sentiment analysis confusion matrix [±0.05].
NLP
Qual ≥0.05 + =-0.05 to <0.05 0 ≤-0.05 Total
Positive 130 26 4 14 174 Agreed evaluation
Mixed 24 9 3 11 47 1 category different
Neutral 0 0 1 3 4 2 categories different
Negative 9 11 2 13 35 Completely opposite evaluation
Total 163 46 10 41 260
Accuracy 0.588
green - Agreed evaluation, beige - 1 category different, plum - 2 categories different, and red - completely opposite evaluation.
TABLE 8 | PreModafinil and PostModafinil 3–5-word ngrams grouped by theme.
Theme/category PreModafinil PostModafinil
Reasons I was diagnosed with; obstructive sleep
apnea; chronic fatigue syndrome; I have
been; sleep apnea and; I suffer from; at
the age of;
Symptoms I have been; that I was; I found myself; I
have to; I suffer from; for the last; I was a;
at the age of; and I was; I used to; I was
still; I wake up; I had to
Other interventions I started taking; I was on;
Acquisition I went to; I was prescribed; I decided to
Dosage Early in the morning; I don’t take it; I have been taking; I started taking; I take it; I don’t
take; I have found that; I took it; I have to; in the morning; on days that I; if I don’t; when I
don’t; to take it
Side effects With no side effects; I didn’t notice; and I was; don’t have; the next day; I don’t feel; the
first time I took; the side effects;
Effectiveness I am able to; I don’t feel; to be able to; get out of bed; I didn’t notice; first time I took; I
began to; and I was; don’t have; the next day; go to sleep; I feel like I; I have found that; I
was able to; I don’t think; I have not; I felt like I; I used to; if I don’t; that I could;
Outcome To go to; to be able to; was able to; that I could; I felt like I;
Temporal All the time; during the day; through the
day; for the last; in the morning;
A few days; first time I took; during the day; for a few days; in the morning and; through
the day; the first time
Sequential For the last; I used to; I was still; At the same time; as soon as I; for the first time; for a few days; the next day: I have found
that; I used to; on days that I; I had to; if I don’t; if I need to; the first time I took; the first
time;
Negation I don’t; I didn’t; Don’t have; I can not; I didn’t feel; I didn’t have; I didn’t notice; I don’t feel; I am not; I did
not; I don’t have; I don’t know; I have not; I do not; I was not; it does not; n’t be able to;
Confirmation I was able to; I felt like I; I want to; I used to; I was on; I had to; it was a;
Ungrouped A lot of A lot of; hours of sleep; I need to; I have been; that I could; that I had; that I have; that I
was; the rest of the; to be a; to take a
Causal ngram I began to; I have found that; on days that I; if I don’t; when I don’t;
the concepts that posters describe in their evaluations include
stopwords or words that may not be evaluated as expressing
sentiment. Improved accuracy will require the development or
use of a domain specific model.
Compared to Current Evidence
These findings of overall effectiveness contrast strongly to the
existing current RCT and systematic review evidence, which
are generally used to determine treatment pathway options for
clinicians (96). Although various RCTs have looked at Modafinil
as a potential therapy across a range of conditions, findings have
been mixed, and the systematic reviews generally conclude that
the evidence is either inconclusive or of insufficient quality (44–
47, 49, 50, 52, 53). This contradiction may have implications on
both on patient care and the efficiency of healthcare provision,
either through the patient not receiving an intervention that may
be effective, or by receiving one that is ineffective (97, 98).
How SGOPE Can Complement RCTs in
Generating Evidence
Our results demonstrate how SGOPE can help address some
of the identified issues with a research driven agenda (15)
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TABLE 9 | Example ngrams in context.
ngram—I have been (PreModafinil)—categorized as “Reason for taking”
I have been battling MS Fatigue to the point of almost thinking of quitting my job, but desperately need the money.
Depression I have been working for many years with one combination after another of medications for bi polar disorder.
Before Nuvigil I have been suffering for the past 3 years or so with marked fatigue.
For the last few years I have been taking medicines to calm me down and ease my stress levels.
With that said, recently I have been back and forth to the doctor for 4 months now.
I have been fighting this for as long as my memory will take me.
I consider my own experiences to be significant in that I have been on the SSRI cipralex (celexa, escitalopram) since age 19, having experienced bouts of diagnosed
major depression in my late teens.
I have been taking Provigil for about 9 months now after my sleep disorder kept me awake for 8 days even after being on a 6mg dose of lorazepam to sleep at night
for several years.
In addition to Provigil I have been on Effexor XR at 150 mg/day for my mild depression.
I have a severe lack of motivation and I have been diagnosed with ADHD.
I have been diagnosed with and suffering from Idiopathic Hypersomnia for the last 6 years.
I have been through 2 sleep studies and I wasn’t quite a match for the CPAP machine but according to my doctor at the Mayo Clinic, there is obviously something
wrong with how tired I am and how easily I can fall asleep.
ngram—I used to (PreModafinil)—categorized as “Symptoms”
I used to fight sleep all day at work, it got to the point where I was staying home because I just couldn’t stay awake.
After the buzz wore off, my life became normal, which was a great improvement over the constant feelings of lethargy and helplessness I used to feel.
As someone who works online, as a writer and retailer, I used to find myself researching an article 1min, and somehow snapping out of a haze a few hours later.
I used to drink coffee for this kind of thing, but tolerance builds up quickly and by the end of exams I’d be drinking a few cups a day and it made me feel no good.
I used to be a PhD student who was heavily dependent on Adderall for a cognitive and motivational boost.
ngram—I have found that—(PostModafinil)—categorized as “Dosage”
I have found that if I don’t take it on the weekends that it works better.
Overall, I have found that effects of Modafinil, for me at least, are extremely subtle and almost unnoticeable until I start to think back and examine the things that I have
done on a given day.
I have found that a very effective remedy is to take a couple of co-codamol tablets, which each contain 8mg of codeine.
I have found that my own lack of worry or guilt in situations like these prevents people from becoming suspicious—nobody batted an eyelid.
The one concern I have is that I have found that cutting the dose (as I did once for several days when I didn’t place the online order in time) seems to have a dramatic
negative effect.
I have found that Modafinil gives me a very clear mind for problem solving.
I have found that if I skip the workout, I don’t have as much energy throughout the day.
I have found that if I eat a lighter lunch, the dip is not as bad.
I have found that overall mod just works best on its own.
ngram—the first time (PostModafinil)-categorized as “Effectiveness,” “Temporal,” and “Sequential”
The first day on Nuvigil I felt like I had never felt before: My mind felt awake for the first time in what seems like forever.
I feel my age for the first time ever!
I have done some research and found that taking a “drug holiday” or going a day or two out of the week without it will help it stay just as potent as the first time I used it.
Like many others, the first time I took it was great!
The first time around, I nearly drove my family crazy with my talking and myself crazy trying to keep my rapid thoughts to myself.
The first time I took it, I did not have the headaches, smelly urine, post nasal drip, fuzzy vision, or muscle aches.
All I can say is that I’m now a 4.0 college student and I feel like I’m actually awake for the first time in my life.
The first time I took this (prescribed for obstructive sleep apnea) I thought “wow, this is the answer!”
At first I was skeptical that it had been the Modafinil that had caused the happiness because I tend to go through short bursts of depression and happiness and I
assumed that I had just been on a good day the first time I took it but looking back I haven’t had any significantly bad days while I was on Modafinil.
I am dramatically more productive at work and for the first time in my like I feel capable of planning for the future.
I will never forget how deep my mind sank that week, it was the first time I’d ever felt truly depressed—not even extended family deaths or the comedown from 220mg
of pure MDMA was as bad as how I was feeling that morning.
When I took it for an exam the first time it was amazing, I took 400mg at around 8 and stayed up the entire night studying with no problems.
I was captivated by his work, which really was excellent (we both received 1st for our efforts), but for the first time that day I was ever so slightly distracted while I
was reading.
The first time, I seriously wondered about the efficacy of the things...
I think it important to note that I have never taken it every day and usually never take more than 200mg. 600 mgs, which I took for the first time today, really has
me jacked.
(Continued)
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TABLE 9 | Continued
The first time I tried Modafinil the effect was immediate.
Right from the first time I took Modafinil not only did I feel better, but I could tell how much more I was worried about my work, the amount of detail I would put into my
projects even shocked myself.
The first time I took modafinil I understood what all the hype was about.
TABLE 10 | Examples of causation reason and consequence.
Document Causation: reason Causation: consequence
1,063 I used to fight sleep all day at work, Once I started Nuvigil I have not had this problem at all, I feel like I have more energy,
and my mental alertness has improved 100%.
1,090 I’ve tried 44 anti-depressants and only got about
25% relief
Nuvigil obliterated my depression and eased my anxiety by about 60%
1,065 Prior to provigil, I would regularly fall asleep at work or in
meetings. I was afraid to drive alone for more than an
hour for fear that I would fall asleep driving (I had many
close calls!).
This drug has made a significant improvement in my quality of life.
1,065 I had felt (just weeks earlier) that I could not go on
any further.
I can keep my job and haven’t wrecked any cars.
1,136 Constant feelings of lethargy and helplessness I used
to feel.
This drug has returned my pre-MS life to me. I can fully function on the job
1,207 I forgot to take it 1 day And could not stay awake and could not stop eating, just like prior to starting Provigil.
and complement RCTs. One of the possible reasons for the
inconclusive trial evidence to date is the heterogeneity of
effect that can occur within trials (99). Trials generally exclude
participants with multiple comorbidities as these may act as
confounders when measuring effectiveness (97) whereas many of
the posters have two or more co-existing conditions, and may use
combinations of interventions, or react to a single intervention in
different ways.
Systematic reviews show how trials report either the effects of
a single dose or a regular daily dose for a limited time (48, 100–
102), whereas our findings include much greater variety of usage
patterns. Our results illustrate how some posters have varied
dosage patterns and amounts to find the optimal dosage regime
for them, with some finding that lower doses than those usually
prescribed were more effective. The data also demonstrated the
existence of a possible tolerance effect but included the suggestion
that taking occasional breaks or taking as required appeared to
be a viable method of retaining effectiveness over time. Identified
side effects generally reflected those already known (94), however
the retrospective nature of the posts enabled the discovery of the
temporary nature of some common side effects, a factor that will
not be reflected in single dose trials.
Identifying Causal Inference
Studies have begun to look at the lexical and grammatical features
of causal statements in free text (84) and some work has been
done using NLP to identify pharmacological adverse events from
social media (33, 103, 104) suggesting that negative effectiveness
can be shown from this type of data. Identifying causal text
requires showing temporality; the effect occurring after the cause.
Dividing the corpus into pre and post intervention by tagging the
tense of tokens facilitated this classification, while ngrams and
other POS tags helped us identify sequential events.
One of the issues of identifying causality in any kind of
study has always been in differentiating between correlation and
causation (105). Identified patterns and correlations can indicate
that “something is happening” but not necessarily explain “why”
(106, 107) as it does not differentiate between the causes of
patterns, whether they are true, coincidental or as a result of
bias. Increasing the volume and range of data may achieve
a higher degree of precision and external validity (108) and
while summarizing and visualization may be useful in analyzing
SGOPE datasets, correlation is not the same as causation and
on its own it is unlikely to be robust enough to add to an
evidence base.
In our study, strength is demonstrated by how almost all
posters reported an effect, either positive, negative or mixed.
By using multiple data sources and including patients with
a wide range of conditions we have shown consistency of
findings across populations. The reported rapid onset of effect
shows specificity and a biological gradient, with the cause/effect
sequencing showing temporality.
The purpose of our research is not to provide a statistical
proof of effectiveness across the whole patient population, but
to generate a better understanding of the patient experience of
using Modafinil, by exploring individual patient’s perspective of
whether or not it is effective for them. Causal dispositionalism
is an alternative theory to the non-reductionist approach to
causation, which may be relevant to this type of data. This takes
a more nuanced view of how the characteristics or dispositions
of both the intervention and the individual combine to affect
the effectiveness (109). Rather than taking a statistically based
population level view, marginal cases, and outliers are used as
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TABLE 11 | Example posts with conflicting sentiment analysis results.
Manual grade negative—NLP grade positive Manual grade positive—NLP grade negative
First day was great (started ar 150 dose) then falling asleep during day.
Increased to 250, didn’t fall asleep during day but very nervous and couldn’t
sleep at night. Going to breakup dosage to see if that helps Side Effects
Itching, can’t sleep at night [1146]
I have sleep apnea and also Multiple Sclerosis. I use the 100mg tab, but not
on a daily basis. I use this when I feel tired from my MS. I recommend this for
MS patients that tend to have no energy when they wake up in the mornings.
It doesn’t seem to affect my symptoms of MS; i.e., the tingling in my feet or
legs. It just gives me energy to get throught the day, when I need to do what
I need to do. I see my Neurologists for the medication prescription. [5037]
a starting point for further investigation of potential predicates
(110). However, nomatter how accurately causal text is identified,
the possibility of a placebo effect, recognized as a powerful factor
in a patient’s assessment of effectiveness both in and out of trials
(111–113) means that it is impossible to tell how much of the
sentiment toward effects, either positive or negative, is due to
such an effect rather than the Modafinil itself.
Strengths and Limitations
Using content purely from the public domain is both a strength
and a limitation. Although the easiest to access, it may not
contain the richest patient experience data, which may be posted
on sites requiring a “login.” However, using public domain
data enables future replication. Validity is increased by using a
diverse range of data sources. Each site comprises posts from a
“community” of people who feel comfortable there, potentially
leading to an element of emotional contagion between the
posters (114, 115). This clustering of individuals can lead to a
confirmation bias as consensus has been shown to have a positive
impact on the perceived effectiveness of treatment (116). Using
multiple sites can mitigate this type of contagion while the scale
of the data being analyzed should negate the problems of an
individual post being incorrectly classified or missed. Although
there will always be an element of the unknown about the
motivations and authenticity of such posts, analyzing them on
a large scale rather than just a small subsection, can negate the
impact of those individuals or organizations who might try to
create an inaccurate impression, while techniques are continually
being developed to identify spam or non-genuine posts.
As the content is generated entirely by the poster, SGOPE
relies on the poster’s self-description of their condition, which
may include self-diagnosis, rather than that of a clinician.
Reporting of symptoms and outcomes may not be as accurate
or complete as it could be although this limitation can
apply to any form of self-reported data, whether in a trial,
clinical encounter, or online. Self-reported data, especially
on hard to measure factors such as fatigue and cognition
is subjective, but generally reflects the normative value of
the patient. The natural, non-clinical language used within
unstructured text can contain valuable information that may
remain unexplored in a clinical or research setting (117), but
it can also contain many spelling or grammatical errors as
well as slang terms or colloquialisms that are problematic
even for NLP methods created for electronic health records
(EHRs) (118).
Future Research
The next study in the project will be a fully NLP based analysis
of a much larger dataset of patient experiences of Modafinil
use. Having identified some of the possibilities and potential
pitfalls, we will use these findings to develop methods that can
be subsequently generalized to evaluate other interventions from
unstructured text.
CONCLUSION
We have demonstrated how SGOPE shows potential for the
identification of perceived causation and evaluation of the
effectiveness of Modafinil. The findings show that in comparison
to the current inconclusive evidence, most posters findModafinil
to be effective in dealing with fatigue and cognitive symptoms
across a wider range of conditions. Our study shows the
potential for new research methods and data sources to augment
existing knowledge. Although the twomethods are very different,
we demonstrate how computational methods can extract the
same main topic areas as qualitative analysis. Although much
work is needed to refine the techniques and address the
challenges identified, our comparison suggests NLP can be
used to look beyond the literal meaning of the words, gaining
an understanding of how posters assess the effectiveness of a
healthcare intervention and the outcomes that they value, on a
much greater scale than is possible from qualitative studies.
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